Viewing Study NCT06070012


Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2025-12-29 @ 2:14 AM
Study NCT ID: NCT06070012
Status: RECRUITING
Last Update Posted: 2025-12-15
First Post: 2023-09-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
Sponsor: Diwakar Davar
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module